These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 32300067
1. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis. Mejia-Vilet JM, Zhang XL, Cruz C, Cano-Verduzco ML, Shapiro JP, Nagaraja HN, Morales-Buenrostro LE, Rovin BH. J Am Soc Nephrol; 2020 Jun; 31(6):1335-1347. PubMed ID: 32300067 [Abstract] [Full Text] [Related]
2. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis. Endo N, Tsuboi N, Furuhashi K, Shi Y, Du Q, Abe T, Hori M, Imaizumi T, Kim H, Katsuno T, Ozaki T, Kosugi T, Matsuo S, Maruyama S. Nephrol Dial Transplant; 2016 Dec; 31(12):2023-2033. PubMed ID: 27242373 [Abstract] [Full Text] [Related]
3. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages. Zhang T, Li H, Vanarsa K, Gidley G, Mok CC, Petri M, Saxena R, Mohan C. Front Immunol; 2020 Dec; 11():671. PubMed ID: 32351512 [Abstract] [Full Text] [Related]
4. Urinary Soluble CD163 in Active Renal Vasculitis. O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA. J Am Soc Nephrol; 2016 Sep; 27(9):2906-16. PubMed ID: 26940094 [Abstract] [Full Text] [Related]
5. Urine Soluble CD163 Is a Promising Biomarker for the Diagnosis and Evaluation of Lupus Nephritis. Huang YJ, Lin CH, Yang HY, Luo SF, Kuo CF. Front Immunol; 2022 Sep; 13():935700. PubMed ID: 35911758 [Abstract] [Full Text] [Related]
6. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis. Mok CC, Soliman S, Ho LY, Mohamed FA, Mohamed FI, Mohan C. Arthritis Res Ther; 2018 Jan 11; 20(1):6. PubMed ID: 29325582 [Abstract] [Full Text] [Related]
7. CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis. Olmes G, Büttner-Herold M, Ferrazzi F, Distel L, Amann K, Daniel C. Arthritis Res Ther; 2016 Apr 18; 18():90. PubMed ID: 27091114 [Abstract] [Full Text] [Related]
8. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis. Aendekerk JP, Timmermans SAMEG, Busch MH, Potjewijd J, Heeringa P, Damoiseaux JGMC, Reutelingsperger CP, van Paassen P, Limburg Renal Registry. Clin J Am Soc Nephrol; 2020 Dec 07; 15(12):1740-1748. PubMed ID: 33203735 [Abstract] [Full Text] [Related]
9. Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis. Inthavong H, Vanarsa K, Castillo J, Hicks MJ, Mohan C, Wenderfer SE. Rheumatology (Oxford); 2023 Mar 01; 62(3):1335-1342. PubMed ID: 35961024 [Abstract] [Full Text] [Related]
10. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA, Vasculitis Clinical Research Consortium. Nephrol Dial Transplant; 2020 Feb 01; 35(2):283-291. PubMed ID: 30380100 [Abstract] [Full Text] [Related]
11. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY. Lupus; 2019 May 01; 28(6):713-721. PubMed ID: 31046570 [Abstract] [Full Text] [Related]
12. The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis. Moran SM, Scott J, Clarkson MR, Conlon N, Dunne J, Griffin MD, Griffin TP, Groarke E, Holian J, Judge C, Wyse J, McLoughlin K, O'Hara PV, Kretzler M, Little MA, Nephrotic Syndrome Study Network (NEPTUNE). J Am Soc Nephrol; 2021 Nov 01; 32(11):2920-2932. PubMed ID: 34518279 [Abstract] [Full Text] [Related]
13. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis. Gupta R, Yadav A, Aggarwal A. Clin Rheumatol; 2021 Mar 01; 40(3):941-948. PubMed ID: 32809146 [Abstract] [Full Text] [Related]
14. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare. Go DJ, Lee JY, Kang MJ, Lee EY, Lee EB, Yi EC, Song YW. Lupus; 2018 Sep 01; 27(10):1600-1615. PubMed ID: 29958502 [Abstract] [Full Text] [Related]
15. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Brunner HI, Mueller M, Rutherford C, Passo MH, Witte D, Grom A, Mishra J, Devarajan P. Arthritis Rheum; 2006 Aug 01; 54(8):2577-84. PubMed ID: 16868980 [Abstract] [Full Text] [Related]
16. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus. Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H. Lupus; 2019 Jul 01; 28(8):986-994. PubMed ID: 31246559 [Abstract] [Full Text] [Related]
17. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study. Gupta R, Yadav A, Misra R, Aggarwal A. Clin Exp Rheumatol; 2015 Jul 01; 33(5):694-8. PubMed ID: 26211517 [Abstract] [Full Text] [Related]
18. Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity. Yang X, Gao Y, Wang H, Zhao X, Gong X, Wang Q, Zhang X. J Rheumatol; 2014 Sep 01; 41(9):1793-800. PubMed ID: 25086075 [Abstract] [Full Text] [Related]
19. Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity. Allam M, Fathy H, Allah DA, Salem MAE. Lupus; 2020 Jul 01; 29(8):943-953. PubMed ID: 32580679 [Abstract] [Full Text] [Related]
20. Association Between Urinary Epidermal Growth Factor and Renal Prognosis in Lupus Nephritis. Mejia-Vilet JM, Shapiro JP, Zhang XL, Cruz C, Zimmerman G, Méndez-Pérez RA, Cano-Verduzco ML, Parikh SV, Nagaraja HN, Morales-Buenrostro LE, Rovin BH. Arthritis Rheumatol; 2021 Feb 01; 73(2):244-254. PubMed ID: 32892508 [Abstract] [Full Text] [Related] Page: [Next] [New Search]